Pharmacogenomic profiling and clarification of the role of the mismatch repair genes in response to the chemotherapeutic agent 5-Fluorouracil in a South African colorectal cancer cohort
Includes abstract. === Includes bibliographical references (leaves 106-120). === To date, surgery is the mainstay treatment for HNPCC. Adjuvant chemotherapy and radiotherapy are often used to reduce systemic and locoregional recurrence, respectively, after curative surgical resection. The main chemo...
Main Author: | Meyer, Jacqueline |
---|---|
Other Authors: | Ramesar, Raj |
Format: | Dissertation |
Language: | English |
Published: |
University of Cape Town
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/3099 |
Similar Items
-
Prognostic Significance of the Mismatch Repair Gene in Colorectal Cancer Patients Treated with 5-Fluorouracil Chemotherapy.
by: Kanet Kanjanapradit, et al.
Published: (2011-02-01) -
Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells
by: Helena de Castro e Gloria, et al.
Published: (2021-04-01) -
MISMATCH REPAIR GENES IN COLORECTAL CARCINOMA
by: Asim Qureshi, et al.
Published: (2015-04-01) -
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
by: Alessia Bignucolo, et al.
Published: (2017-07-01) -
Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS.
by: Amaya Rando, et al.
Published: (2019-01-01)